|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 25, 2018 - Apr 30, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||20.00|
MRI Interventions, Inc. (MRIC) announced that it will webcast its presentation at the 8th annual LD Micro Invitational Conference on Tuesday, June 5. Joe Burnett, Chief Executive Officer, is scheduled to present at 11:00 am Pacific Time. Building on the imaging power of magnetic resonance imaging (“MRI”), MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. The ClearPoint Neuro Navigation System, which has received 510(k) clearance and is CE marked, utilizes a hospital’s existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain.
MRI Interventions, Inc. (MRIC), a commercial stage medical device company focused on Magnetic Resonance Imaging (MRI)-Guided Neurosurgical procedures, today announced that its ClearPoint® Neuro Navigation System will be featured in a symposium, entitled “ClearPoint Precision Guided Therapy – Making the Most of Your Magnet,” on Sunday, June 3, 2018 at the Biennial Meeting of the American Society for Stereotactic and Functional Neurosurgery (ASSFN) taking place in Denver, Colorado June 2-5, 2018. The symposium will feature a variety of case studies including DBS lead placement, laser ablation and convection enhanced drug delivery utilizing the sub-millimetric precision of real-time MRI navigation with ClearPoint.
LOS ANGELES, CA / ACCESSWIRE / May 22, 2018 / MRI Interventions, Inc. (OTCQB: MRIC), today announced that Chief Executive Officer Joe Burnett will present at the 8th annual LD Micro Invitational on Tuesday, ...
IRVINE, Calif., May 22, 2018-- MRI Interventions, Inc. today announced that Chief Executive Officer Joe Burnett will present at the 8th annual LD Micro Invitational on Tuesday, June 5 at 11:00 AM PDT. ...
MRI Interventions, Inc. (MRIC) a leader in Precision MRI-Guided Therapy, including Biologics and Drug Delivery, today announced CE Mark approval for the SmartFlow Cannula. “We are thrilled to provide, what we believe, is this best-in-class delivery cannula to our biologics and drug-delivery partners in Europe and other CE Mark geographies,” commented Joe Burnett, President and CEO of MRI Interventions.
MRI Interventions, Inc. (MRIC) today announced a strategic agreement with Voyager Therapeutics, Inc. (VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases.
IRVINE, Calif., May 15, 2018-- MRI Interventions, Inc. today announced financial results for its first fiscal quarter ended March 31, 2018.. Total revenue decreased 19% to $1.6 million for the first quarter ...
IRVINE, Calif., May 09, 2018-- MRI Interventions, Inc. announced that it will release financial results for its 2018 first quarter, which ended March 31, 2018, on Tuesday, May 15, 2018 after the market ...
NEW YORK, NY / ACCESSWIRE / March 27, 2018 / MRI Interventions, Inc. (OTCQB: MRIC), today announced that Joe Burnett, CEO, will present at the MicroCap Conference on April 9th and 10th at the Essex House ...
NEW YORK, NY / ACCESSWIRE / March 15, 2018 / MRI Interventions, Inc. (OTCQB: MRIC ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 15, 2018, at 4:15 PM Eastern ...
NEW YORK, NY / ACCESSWIRE / November 6, 2017 / MRI Interventions, Inc. (OTCQB: MRIC ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 6, 2017 at 4:30 PM Eastern ...
Categories: Yahoo FinanceGet free summary analysis MRI Interventions, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 1.98 million, Net Earnings of USD -2.00 million. Gross margins widened from 52.80% to 59.59% compared to the same period last year, operating (EBITDA) margins now -90.72% from -181.85%. Change in operating ... Read more (Read more...)